{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T15:44:59Z","timestamp":1782747899205,"version":"3.54.5"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007937","name":"Peking University","doi-asserted-by":"publisher","award":["RS2020-03"],"award-info":[{"award-number":["RS2020-03"]}],"id":[{"id":"10.13039\/501100007937","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007937","name":"Peking University","doi-asserted-by":"publisher","award":["RDY2020-29"],"award-info":[{"award-number":["RDY2020-29"]}],"id":[{"id":"10.13039\/501100007937","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005090","name":"Beijing Nova Program","doi-asserted-by":"publisher","award":["0107050"],"award-info":[{"award-number":["0107050"]}],"id":[{"id":"10.13039\/501100005090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005090","name":"Beijing Nova Program","doi-asserted-by":"publisher","award":["Z211100002121058"],"award-info":[{"award-number":["Z211100002121058"]}],"id":[{"id":"10.13039\/501100005090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["BMU2021PYB005"],"award-info":[{"award-number":["BMU2021PYB005"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82100168"],"award-info":[{"award-number":["82100168"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Pathogenesis and Therapy"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.cpt.2025.08.002","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T16:01:51Z","timestamp":1755878511000},"page":"310-320","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Enoyl-CoA hydratase domain-containing protein 3 (ECHDC3) regulates mitochondrial metabolism and chemotherapy resistance in acute myeloid leukemia (AML)"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-7531-1528","authenticated-orcid":false,"given":"Yijing","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanfei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liting","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpt.2025.08.002_bib1","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(23)00108-3","article-title":"Acute myeloid leukaemia","volume":"401","author":"DiNardo","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.cpt.2025.08.002_bib2","doi-asserted-by":"crossref","DOI":"10.1172\/JCI160152","article-title":"Targeting acetylcholine signaling modulates persistent drug tolerance in EGFR-mutant lung cancer and impedes tumor relapse","volume":"132","author":"Nie","year":"2022","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cpt.2025.08.002_bib3","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1038\/s42255-023-00927-3","article-title":"A century of the Warburg effect","volume":"5","author":"Thompson","year":"2023","journal-title":"Nat Metab"},{"key":"10.1016\/j.cpt.2025.08.002_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-48970-0","article-title":"Metabolomic profile of acute myeloid leukaemia parallels of prognosis and response to therapy","volume":"13","author":"Bolkun","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.cpt.2025.08.002_bib5","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.ccell.2018.10.005","article-title":"Inhibition of amino acid metabolism selectively targets human leukemia stem cells","volume":"34","author":"Jones","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cpt.2025.08.002_bib6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3389\/fonc.2020.00155","article-title":"Fatty acid metabolism, bone marrow adipocytes, and AML","volume":"10","author":"Tabe","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.cpt.2025.08.002_bib7","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2210796120","article-title":"Redox metabolism maintains the leukemogenic capacity and drug resistance of AML cells","volume":"120","author":"Huang","year":"2023","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cpt.2025.08.002_bib8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12943-022-01526-8","article-title":"Proteomics technologies for cancer liquid biopsies","volume":"21","author":"Ding","year":"2022","journal-title":"Mol Cancer"},{"key":"10.1016\/j.cpt.2025.08.002_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101159","article-title":"Targeting IFN-\u03b3-inducible lysosomal thiol reductase overcomes chemoresistance in AML through regulating the ROS-mediated mitochondrial damage","volume":"14","author":"Niu","year":"2021","journal-title":"Transl Oncol"},{"key":"10.1016\/j.cpt.2025.08.002_bib10","article-title":"Comprehensive analysis of ECHDC3 as a potential biomarker and therapeutic target for acute myeloid leukemia: bioinformatic analysis and experimental verification","volume":"12","author":"Zhao","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.cpt.2025.08.002_bib11","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"Dohner","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.cpt.2025.08.002_bib12","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/bjh.16526","article-title":"Mutation topography and risk stratification for de novo acute myeloid leukaemia with normal cytogenetics and no nucleophosmin 1 (NPM1) mutation or Fms-like tyrosine kinase 3 internal tandem duplication (FLT3-ITD)","volume":"190","author":"Zhou","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cpt.2025.08.002_bib13","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.canlet.2018.08.030","article-title":"The consensus on the monitoring, treatment, and prevention of leukemia relapse after allogeneic hematopoietic stem cell transplantation in China","volume":"438","author":"Wang","year":"2018","journal-title":"Cancer Lett"},{"key":"10.1016\/j.cpt.2025.08.002_bib14","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.celrep.2017.06.074","article-title":"Proteomic and Metabolomic Characterization of a Mammalian Cellular Transition from Quiescence to Proliferation","volume":"20","author":"Lee","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.cpt.2025.08.002_bib15","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/nprot.2011.335","article-title":"Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry","volume":"6","author":"Dunn","year":"2011","journal-title":"Nat Protoc"},{"key":"10.1016\/j.cpt.2025.08.002_bib16","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.3390\/ijms232415893","article-title":"Insights into manganese superoxide dismutase and human diseases","volume":"23","author":"Liu","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cpt.2025.08.002_bib17","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.7150\/ijbs.51184","article-title":"MnSOD Lysine 68 acetylation leads to cisplatin and doxorubicin resistance due to aberrant mitochondrial metabolism","volume":"17","author":"Gao","year":"2021","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.cpt.2025.08.002_bib18","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1186\/1471-2164-15-539","article-title":"ChIPseek, a web-based analysis tool for ChIP data","volume":"15","author":"Chen","year":"2014","journal-title":"BMC Genom"},{"key":"10.1016\/j.cpt.2025.08.002_bib19","doi-asserted-by":"crossref","first-page":"5604","DOI":"10.1182\/blood-2011-04-348052","article-title":"Abnormal expression of FLI1 protein is an adverse prognostic factor in acute myeloid leukemia","volume":"118","author":"Kornblau","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.cpt.2025.08.002_bib20","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1182\/blood.2020009707","article-title":"Disruption of a GATA2-TAL1-ERG regulatory circuit promotes erythroid transition in healthy and leukemic stem cells","volume":"138","author":"Thoms","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.cpt.2025.08.002_bib21","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/j.celrep.2016.08.082","article-title":"The hematopoietic transcription factors RUNX1 and ERG prevent AML1-ETO oncogene overexpression and onset of the apoptosis program in t(8;21) AMLs","volume":"17","author":"Mandoli","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.cpt.2025.08.002_bib22","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41408-021-00514-3","article-title":"Acute promyelocytic leukemia current treatment algorithms","volume":"11","author":"Yilmaz","year":"2021","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.cpt.2025.08.002_bib23","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1182\/bloodadvances.2022008806","article-title":"Targeting RARA overexpression with tamibarotene, a potent and selective RAR\u03b1 agonist, is a novel approach in AML","volume":"7","author":"de Botton","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.cpt.2025.08.002_bib24","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.ccell.2018.10.005","article-title":"Inhibition of amino acid metabolism selectively targets human leukemia stem cells","volume":"34","author":"Jones","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cpt.2025.08.002_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1199354","article-title":"Editorial: acute leukemias: molecular characterization, leukemia-initiating cells, and influence of the microenvironment","volume":"13","author":"Dancik","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.cpt.2025.08.002_bib26","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41420-024-02226-6","article-title":"Mitophagy: insights into its signaling molecules, biological functions, and therapeutic potential in breast cancer","volume":"10","author":"Chen","year":"2024","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.cpt.2025.08.002_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.mito.2024.101847","article-title":"Mitochondrial dynamics and mitochondrial autophagy: molecular structure, orchestrating mechanism and related disorders","volume":"75","author":"Wang","year":"2024","journal-title":"Mitochondrion"},{"key":"10.1016\/j.cpt.2025.08.002_bib28","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3390\/biom13020226","article-title":"Mitochondrial modulators: the defender","volume":"13","author":"Makinde","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.cpt.2025.08.002_bib29","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1158\/2159-8290.CD-22-0601","article-title":"Mitophagy promotes resistance to BH3 mimetics in acute myeloid leukemia","volume":"13","author":"Glytsou","year":"2023","journal-title":"Cancer Discov"},{"key":"10.1016\/j.cpt.2025.08.002_bib30","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3390\/biom11030428","article-title":"Phospholipases: from structure to biological function","volume":"11","author":"Balboa","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.cpt.2025.08.002_bib31","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.plipres.2013.10.001","article-title":"Acyltransferases and transacylases that determine the fatty acid composition of glycerolipids and the metabolism of bioactive lipid mediators in mammalian cells and model organisms","volume":"53","author":"Yamashita","year":"2014","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.cpt.2025.08.002_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceb.2023.102192","article-title":"Phosphatidylserine transport in cell life and death","volume":"83","author":"\u010copi\u010d","year":"2023","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.cpt.2025.08.002_bib33","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1002\/1878-0261.12959","article-title":"SMAC\/Diablo controls proliferation of cancer cells by regulating phosphatidylethanolamine synthesis","volume":"15","author":"Pandey","year":"2021","journal-title":"Mol Oncol"},{"key":"10.1016\/j.cpt.2025.08.002_bib34","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.stem.2019.02.020","article-title":"The mitochondrial transacylase, tafazzin, regulates for AML stemness by modulating intracellular levels of phospholipids","volume":"24","author":"Seneviratne","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.cpt.2025.08.002_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1146721","article-title":"Inhibiting efferocytosis reverses macrophage-mediated immunosuppression in the leukemia microenvironment","volume":"14","author":"Cruz Cruz","year":"2023","journal-title":"Front Immunol"}],"container-title":["Cancer Pathogenesis and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949713225000928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949713225000928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T14:57:27Z","timestamp":1782745047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949713225000928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2949713225000928"],"URL":"https:\/\/doi.org\/10.1016\/j.cpt.2025.08.002","relation":{},"ISSN":["2949-7132"],"issn-type":[{"value":"2949-7132","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enoyl-CoA hydratase domain-containing protein 3 (ECHDC3) regulates mitochondrial metabolism and chemotherapy resistance in acute myeloid leukemia (AML)","name":"articletitle","label":"Article Title"},{"value":"Cancer Pathogenesis and Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpt.2025.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of Chinese Medical Association (CMA).","name":"copyright","label":"Copyright"}]}}